Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Rodatristat ethyl decreases activity in pulmonary arterial hypertension: results from the ELEVATE-2 trial.
Journal: Annals of the American Thoracic Society
Published: May 08, 2025
Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis.
Journal: BMJ open respiratory research
Published: December 13, 2024
Improved quality of life, reduced quantitative lung fibrosis in a trial of inhaled pirfenidone for idiopathic pulmonary fibrosis.
Journal: BMC pulmonary medicine
Published: November 27, 2024
Safety and efficacy of rodatristat ethyl for the treatment of pulmonary arterial hypertension (ELEVATE-2): a dose-ranging, randomised, multicentre, phase 2b trial.
Journal: The Lancet. Respiratory medicine
Published: March 28, 2024
Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
Journal: Comprehensive Physiology
Published: August 29, 2022
A trial design to maximize knowledge of the effects of rodatristat ethyl in the treatment of pulmonary arterial hypertension (ELEVATE 2).
Journal: Pulmonary circulation
Published: November 05, 2021
Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis: Global Pharmacovigilance Data.
Journal: Advances in therapy
Published: May 29, 2020
Design of Idiopathic Pulmonary Fibrosis Clinical Trials in the Era of Approved Therapies.
Journal: American journal of respiratory and critical care medicine
Published: April 16, 2019
Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States.
Journal: Journal of managed care & specialty pharmacy
Published: February 14, 2018
Last Updated: 09/26/2026